menu
    • menu

    Company profile for Rondo Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rondo Therapeutics is a biopharmaceutical company dedicated to advancing cancer immunotherapies, particularly for solid tumors that are unresponsive to current treatments. Rondo's pipeline features multiple bispecific antibody programs, including RNDO-564 targeting CD28 and Nectin-4 for bladder cancer, and other programs in lead optimization and discovery stages for ovarian and undisclosed indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rondo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    25801 Industrial Blvd. Ste. 500 Hayward, CA 94545
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rondotx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rondo Therapeutics Launches Phase 1 RNDO-564 Trial
    Rondo Therapeutics Launches Phase 1 RNDO-564 Trial

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203549891/en/Rondo-Therapeutics-Doses-First-Patient-in-Phase-1-Trial-of-RNDO-564-a-First-in-Class-Co-Stimulatory-Bispecific-Antibody-Targeting-Nectin-4-in-Advanced-Solid-Tumors

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    AbTherx, Rondo Partner on Multi-Program Antibody Discovery
    AbTherx, Rondo Partner on Multi-Program Antibody Discovery

    23 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/abtherx-and-rondo-therapeutics-announce-multi-program-antibody-discovery-collaboratio-1018422

    ACCESSWIRE
    23 Apr 2025
    Share Share
    Rondo Therapeutics Releases Data on RNDO-564 for Bladder Cancer
    Rondo Therapeutics Releases Data on RNDO-564 for Bladder Cancer

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408222894/en/Rondo-Therapeutics-Publishes-Preclinical-Data-on-RNDO-564-a-Novel-CD28-x-Nectin-4-Co-Stimulatory-Bispecific-Antibody-for-the-Treatment-of-Bladder-Cancer

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    Rondo Therapeutics Presents Preclinical Data in Bladder Cancer
    Rondo Therapeutics Presents Preclinical Data in Bladder Cancer

    10 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250210179016/en

    BUSINESSWIRE
    10 Feb 2025
    Share Share
    Thomas Manley, M.D. Joins Rondo Therapeutics as CMO
    Thomas Manley, M.D. Joins Rondo Therapeutics as CMO

    19 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241119420126/en

    BUSINESSWIRE
    19 Nov 2024
    Share Share
    Steven James Joins Rondo Therapeutics Board Of Directors
    Steven James Joins Rondo Therapeutics Board Of Directors

    02 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240702603290/en

    BUSINESSWIRE
    02 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search